Hepion Pharmaceuticals Inc (HEPA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 06-2017 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,037 | -9,449 | -7,511 | -14,891 | -16,999 |
| Depreciation Amortization | 513 | 19 | 11 | 28 | 22 |
| Income taxes - deferred | 48 | -536 | -373 | N/A | N/A |
| Other Working Capital | -826 | -971 | -19 | -1,841 | 3,327 |
| Other Operating Activity | -263 | -4,709 | -317 | -2,468 | -2,905 |
| Operating Cash Flow | $-7,565 | $-15,646 | $-8,209 | $-19,172 | $-16,555 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -52 | 1 | N/A | -15 | -7 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -496 |
| Investing Cash Flow | $-52 | $1 | $N/A | $-15 | $-502 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,119 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 19,827 | 1,778 | 1,181 | 24,776 | 19,898 |
| Other Financing Activity | 0 | 10,746 | 0 | -10 | 0 |
| Financing Cash Flow | $18,707 | $12,524 | $1,181 | $24,766 | $19,898 |
| Beginning Cash Position | 2,832 | 5,954 | 12,983 | 7,404 | 4,563 |
| End Cash Position | 13,923 | 2,832 | 5,954 | 12,983 | 7,404 |
| Net Cash Flow | $11,091 | $-3,122 | $-7,029 | $5,579 | $2,841 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,565 | -15,646 | -8,209 | -19,172 | -16,555 |
| Capital Expenditure | -52 | N/A | 0 | -15 | -7 |
| Free Cash Flow | -7,617 | -15,646 | -8,209 | -19,187 | -16,562 |